|
Report No. : |
352534 |
|
Report Date : |
09.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
DURAMED INTERNATIONAL CORPORATION |
|
|
|
|
Registered Office : |
1F, No.2-5, Lane146,Ta Tung S, Rd., Sanchong Dist., New Taipei City
241 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
19.11.2002 |
|
|
|
|
Com. Reg. No.: |
80083045 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Trading of medical products |
|
|
|
|
Employees: |
About 20 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Taiwan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
TAIWAN - ECONOMIC OVERVIEW
Taiwan has a dynamic capitalist economy with gradually decreasing
government guidance of investment and foreign trade. Exports, led by
electronics, machinery, and petrochemicals have provided the primary impetus
for economic development. This heavy dependence on exports exposes the economy
to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate,
and rapidly aging population are other major long-term challenges.
Free trade agreements have proliferated in East Asia over the past
several years. Following the landmark Economic Cooperation Framework Agreement
(ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade
deal with New Zealand - Taipei’s first-ever with a country with which it does
not maintain diplomatic relations - and, in November, inked a trade pact with
Singapore. However, follow-on components of the ECFA, including a signed
agreement on trade in services and negotiations on trade in goods and dispute
resolution, have stalled. In early 2014, the government bowed to public demand
and proposed a new law governing the oversight of cross-Strait agreements,
before any additional deals with China are implemented; the legislature has yet
to vote on such legislation, leaving the future of ECFA up in the air as
President MA enters his final full year in office. MA has portrayed ECFA as
Taiwan’s key to greater participation in East Asia’s free trade networks.
Taiwan's total fertility rate of just over one child per woman is among
the lowest in the world, raising the prospect of future labor shortages,
falling domestic demand, and declining tax revenues. Taiwan's population is
aging quickly, with the number of people over 65 expected to account for nearly
20% of the island's total population by 2025.
The island runs a trade surplus, largely because of its surplus with
China, and its foreign reserves are the world's fifth largest, behind those of
China, Japan, Saudi Arabia, and Switzerland. In 2006 China overtook the US to
become Taiwan's second-largest source of imports after Japan. China is also the
island's number one destination for foreign direct investment. Taiwan since
2009 has gradually loosened rules governing Chinese investment on the island
and has also secured greater market access for its investors in the mainland.
In August 2012, the Taiwan Central Bank signed a memorandum of understanding
(MOU) on cross-Strait currency settlement with its Chinese counterpart. The MOU
allows for the direct settlement of Chinese RMB and the New Taiwan dollar
across the Strait, which has helped Taiwan develop into a local RMB hub.
Closer economic links with the mainland bring greater opportunities for
Taiwan’s economy but also pose new challenges as the island becomes more
economically dependent on China at a time when political differences remain
unresolved. During 2014, the press paid increasing attention to domestic
economic issues, while pushing aside the debates over trade liberalization that
were a hallmark of MA’s tenure. The media focused on the divide between
Taiwan’s “haves” and “have nots,” providing extensive coverage of public
frustration with stagnant wages, skyrocketing housing prices, and the
difficulty of finding decent entry-level jobs.
|
Source
: CIA |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
3/F., No.22, 5th
Wuquan Rd., Wugu Dist., New Taipei City, Taiwan |
|
Supplied Address: |
IIND FLOOR, NO.
82-8, SEC.1, GUANG FU ROAD, SAN CHUNG CITY, TAIPEI,TAIWAN R.O.C. |
|
Telephone Number: |
+886-2-8512-3867/2-2299-2296 |
|
Fax Number: |
|
|
E-mail: |
Notes: the exact name and address are as above.
|
Registered Name: |
DURAMED INTERNATIONAL CORPORATION |
|
Registered Address: |
1F, No.2-5, Lane146,Ta Tung S, Rd., Sanchong
Dist., New Taipei City 241, Taiwan (R.O.C.) |
|
Date of Foundation: |
2002-11-19 |
|
Registration Number: |
80083045 |
|
Registry: |
New Taipei City Government |
|
Registered Capital: |
(As of 2015.12, 1 NTD = 0.031 USD) |
|
Paid-up Capital: |
NTD 6,000,000 (USD 186,000) |
|
Legal Representatives: |
Zhiqiang Yao |
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed at Stock Exchange: |
|
|
Date of Last Annual Return: |
Subject was incorporated
on 2002-11-19 with registered number 80083045
as Joint Stock Company in Taiwan.
Subject did not register any subsidiaries or branches; from other source
we could not obtain the relevant information, either.
Major Shareholders
|
Name |
Subscription Shares |
|
Zhiqiang Yao |
|
|
150,000 |
|
|
Qingtang Chen |
150,000 |
|
Ruizhen Chen |
150,000 |
|
Qingxiang Chen |
150,000 |
Core Management
Directors
|
1 |
||
|
Name |
Zhiqiang Yao |
|
|
Position |
Chairman of the Board |
|
|
2 |
||
|
Name |
Qingtang Chen |
|
|
Position |
Director |
|
|
3 |
||
|
Name |
Ruizhen Chen |
|
|
Position |
Director |
|
|
4 |
||
|
Name |
Qingxiang Chen |
|
|
Position |
Supervisor |
|
Personnel
Structure
|
Total Employees |
About 20 Employees |
Offices &
Factories
|
|
Headquarters |
|
Add |
3/F., No.22, 5th Wuquan Rd., Wugu Dist., New Taipei City,
Taiwan |
Production
Information
Subject is a trader of medical products without any production
activities.
Subject’s products obtained the certification of ISO 9001, ISO 9002, CE 0086
and ISO-14001, etc.
Purchase
Information
The registered activities of subject:
|
Business Code |
Details |
|
F108031 |
Medical instrument wholesaling |
|
F208031 |
Medical instrument retailing |
|
F113030 |
Precise instrument wholesaling |
|
F213040 |
Precise instrument retailing |
|
F113061 |
Weights and measures wholesaling |
|
F213051 |
Weights and measures retailing |
|
F108040 |
Cosmetic wholesaling |
|
F208040 |
Cosmetic retailing |
|
EZ05010 |
Instrument and apparatus installation engineering |
|
E604010 |
Machinery installation |
|
F301030 |
General department stores |
|
F401181 |
Import of weights and measures |
|
F106020 |
Daily supplies wholesaling |
|
F199990 |
Other wholesales |
|
F203010 |
Food grocery, beverage retailing |
|
F401010 |
International trade |
|
ZZ99999 |
Besides licensed business, all other business items those are not
banned or restricted |
The products of subject are purchased from both home and abroad.
Subject is engaged in sales of medical
products, etc.
The products of subject are mainly applied for hospital, beauty clinic,
department of dentistry, department of orthopaedics, ENT, respiratory care
center and maintenance center, etc.
The brands of subject’s products are Medipack, Kiato, Kawe, Ribbel and
PAK, etc.
It is introduced that subject sells the products mainly in domestic
market.
Subject’s major customers are hospitals and clinics, etc.
Major Products
|
Operating room products |
Surgical blade (handle), surgical marker, gloves, electric pettifoggery,
electrotome conducting strip, coagulator clean sheet, tie-on ear loop
welding, etc. |
|
General eisai |
Tape, gauze, urine bag and mask, etc. |
|
Nurse working place products |
Sphygmomanometer, pulse oximeter, work car, electric bed, etc. |
|
Breath therapy series products |
Oxygen mask, AMBU, breathing circuit, CPR mask, |
|
Disposable laryngeal mirror series |
Disposable laryngeal mirror blades, |
|
Home health care |
Anderson Nitril glove |
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Products |
Medical products, etc. |
|
Payment Terms |
T/T, Cash, etc. |
Import
|
Products |
Medical products, etc. |
|
Payment Terms |
L/C, T/T, etc. |
Domestic Markets
|
Product |
Medical products, etc. |
|
Selling Terms |
T/T, Cash, etc. |
Export
Subject has little export.
Subject has no obligations to disclose its
financial statements to the third party according to the relevant policy in Taiwan
and the only source from which we can obtain the information is the subject
itself.
Subject’s relevant staff declined to disclose
its financials citing the grounds of company’s confidentiality; from other
sources we could not obtain such information, either.
Subject declined to disclose its bank details; from other source we
could not obtain the relevant information, either.
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of reporting, no existing or latent
litigation of the subject has been found.
Interview Details
|
Name |
Ms. Lin |
|
Position |
Sales Department |
|
E-mail |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.80 |
|
|
1 |
Rs.100.49 |
|
Euro |
1 |
Rs.72.52 |
|
TWD |
1 |
Rs.2.03 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
HEE |
|
|
|
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.